enGene to Participate in Upcoming Investor Conferences
BOSTON & MONTREAL — enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company today announced that management will participate in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference Date: Tuesday, September 8, 2026 Time: 10:15 a.m. ET Format: Fireside Chat Morgan Stanley 24th Annual Global Healthcare…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Satellos to Participate in Upcoming Investor Conferences financialpost.com